What is Emergent Biosolutions's operating cash flow?

Emergent Biosolutions (EBS) reported operating cash flow of -$33.8M in Q1 2026.

How has Emergent Biosolutions's operating cash flow changed year-over-year?

Emergent Biosolutions's operating cash flow decreased by 201.8% year-over-year, from -$11.2M to -$33.8M.

What does operating cash flow mean?

Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.

Emergent Biosolutions EBS Operating Cash Flow

Operating Cash Flow at other companies

Thermo Fisher ScientificTMO

$1.19B+64.9%

Regeneron PharmaceuticalsREGN

$1.08B+3.2%

AMP

Amphastar PharmaceuticalsAMPH

$47.84M+36.4%

Amneal Pharmaceuticals, Inc.AMRX

-$26.74M-461%

CorMedixCRMD

$42.38M+115%

Collegium Pharmaceutical, Inc.COLL

$57.11M+3.1%

Other financials

Income statement

See full

Revenue$156.1M-29.7%

Gross profit$84.1M-37.1%

Operating income$10.5M-79.0%

Net income$6.8M-90.0%

EPS (diluted)$0.07-94.1%

Balance sheet

See full

Cash & equivalents$161.5M+5.7%

Total debt$584.6M-13.1%

Total equity$523.1M-5.4%

Total assets$1.3B-7.4%

Cash flow

See full

CapEx$2.4M-33.3%

Free cash flow-$36.2M-145%

Valuation

See full

Market cap$411.74M+22.0%

Enterprise value$834.84M-2.6%

P/E3.6×—

P/S0.6×+0.3×

Profitability

See full

Gross margin54.2%+19.0pp

Operating margin15%+10.3pp

Net margin9.6%+5.8pp

FCF margin20.8%—

Returns & leverage

See full

Return on equity13.9%+8.1pp

Debt / equity1.1×-0.1×

Current ratio4.3×-2.0×

Where this comes from

Reported directly by Emergent Biosolutions in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The official record: Emergent Biosolutions’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Emergent Biosolutions's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Emergent Biosolutions's operating cash flow?: Emergent Biosolutions (EBS) reported operating cash flow of -$33.8M in Q1 2026.
How has Emergent Biosolutions's operating cash flow changed year-over-year?: Emergent Biosolutions's operating cash flow decreased by 201.8% year-over-year, from -$11.2M to -$33.8M.
What does operating cash flow mean?: Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.